This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ADMANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Disney (DIS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Disney (DIS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DISNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Workday (WDAY): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Workday (WDAY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WDAYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Chewy (CHWY): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Chewy (CHWY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CHWYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Carnival (CCL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Carnival (CCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CCLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Energy Fuels (UUUU) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Energy Fuels (UUUU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UUUUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Riot Platforms, Inc. (RIOT): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Riot Platforms, Inc. (RIOT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RIOTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Enterprise Products (EPD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Enterprise Products (EPD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
EPDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
McDonald's (MCD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), McDonald's (MCD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MCDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Marvell (MRVL): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MRVLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Alibaba (BABA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Alibaba (BABA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BABANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Celsius (CELH) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celsius (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CELHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Novo Nordisk (NVO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NVOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Wells Fargo (WFC): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Wells Fargo (WFC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
WFCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Synopsys (SNPS): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SNPSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Modine (MOD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Modine (MOD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MODPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Energy Transfer LP (ET) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Energy Transfer LP (ET) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ETNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Leidos (LDOS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Leidos (LDOS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Canoo (GOEV) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Canoo (GOEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Ares Capital (ARCC) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ares Capital (ARCC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARCCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in AGNC Investment (AGNC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AGNC Investment (AGNC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AGNCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Citigroup (C) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Citigroup (C) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in QuickLogic (QUIK): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for QuickLogic (QUIK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
QUIKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is ASML (ASML) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ASML (ASML) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ASMLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth